FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:54-55 July 3, 1997 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Intravenous multivitamin solution has not been manufactured in the United States for some time, and supplies are nearly depleted. Thus, since the end of 1996 this preparation has not been available for many patients requiring parenteral nutrition.

A 41-year-old woman with spindle-cell cancer underwent a massive small-bowel resection in February 1996 that resulted in short-bowel syndrome. She was receiving total parenteral nutrition while being cared for at home. She received her last dose of intravenous multivitamin solution in the total parenteral nutrition in November 1996. In January 1997 she was hospitalized with nausea, vomiting, vertigo, and diplopia. . . . [Full Text of this Article]

This article has been cited by other articles:

• Robien, K., Ulrich, C. M., Bigler, J., Yasui, Y., Gooley, T., Bruemmer, B., Potter, J. D., Radich, J. P. (2004). Methylenetetrahydrofolate Reductase Genotype Affects Risk of Relapse after Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia. Clin. Cancer Res. 10: 7592-7598 [Abstract] [Full Text]  
• Hahn, J. S., Berquist, W., Alcorn, D. M., Chamberlain, L., Bass, D. (1998). Wernicke Encephalopathy and Beriberi During Total Parenteral Nutrition Attributable to Multivitamin Infusion Shortage. Pediatrics 101 : e10-e10 [Abstract] [Full Text]